14-N-Acetyl-tetrandrine

ID: ALA4103348

PubChem CID: 130422407

Max Phase: Preclinical

Molecular Formula: C40H45N3O7

Molecular Weight: 679.81

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(NC(C)=O)c2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@H](C2)N(C)CC3

Standard InChI:  InChI=1S/C40H45N3O7/c1-23(44)41-30-22-34(46-5)35-20-27(30)17-32-38-26(13-15-43(32)3)19-37(47-6)39(48-7)40(38)50-36-21-29-25(18-33(36)45-4)12-14-42(2)31(29)16-24-8-10-28(49-35)11-9-24/h8-11,18-22,31-32H,12-17H2,1-7H3,(H,41,44)/t31-,32-/m0/s1

Standard InChI Key:  IKEUJTMLULSZNJ-ACHIHNKUSA-N

Molfile:  

     RDKit          2D

 52 58  0  0  0  0  0  0  0  0999 V2000
    5.6075   -8.3122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6063   -9.1317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3144   -9.5407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0240   -9.1313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0212   -8.3086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3126   -7.9033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2379   -3.3118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2367   -4.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9448   -4.5403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9430   -2.9030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8976   -3.4751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3142   -4.2942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3113   -3.4715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6027   -3.0662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6045   -4.7036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8933   -4.2961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1887   -4.7059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1891   -5.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9003   -5.9325    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6111   -5.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6040   -2.2508    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8951   -1.8443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0199   -3.0616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0168   -2.2444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8645   -4.9286    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.6516   -3.3082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6522   -4.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3614   -4.5402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0746   -4.1305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0741   -3.3073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3603   -2.8939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5319   -2.8995    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8243   -3.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9021   -6.7497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3207   -5.9263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2648   -9.4149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2518   -8.1843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2507   -9.0038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9587   -9.4128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6684   -9.0033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6656   -8.1807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9569   -7.7754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3122  -10.3533    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0198  -10.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8997   -7.9038    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1921   -8.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4843   -7.9041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1923   -9.1297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.3717   -7.7694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0639   -4.9485    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.6048   -6.3353    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   12.7821   -4.5396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 27  2  0
 26 10  2  0
 10  7  1  0
 11 16  2  0
 15 12  2  0
 12 13  1  0
 13 14  2  0
 14 11  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 22  1  0
 14 21  1  0
 23 24  1  0
 13 23  1  0
 12 25  1  0
 25  8  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 32 33  1  0
  7 32  1  0
 19 34  1  0
 20 35  1  0
 35  6  1  0
  4 36  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42 37  1  0
 36 38  1  0
 43 44  1  0
  3 43  1  0
  1 45  1  0
 45 46  1  0
 46 47  1  0
 46 48  2  0
 41 49  1  0
 49 28  1  0
 28 50  1  6
 20 51  1  1
 29 52  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4103348

    ---

Associated Targets(Human)

PLC-PRF-5 (244 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 679.81Molecular Weight (Monoisotopic): 679.3258AlogP: 7.12#Rotatable Bonds: 5
Polar Surface Area: 90.96Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 5.72CX LogD: 4.64
Aromatic Rings: 4Heavy Atoms: 50QED Weighted: 0.24Np Likeness Score: 1.22

References

1. Lan J, Wang N, Huang L, Liu Y, Ma X, Lou H, Chen C, Feng Y, Pan W..  (2017)  Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma.,  127  [PMID:28109948] [10.1016/j.ejmech.2017.01.008]

Source